Clinical Trial Update: Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults [Phase 2]

View source ↗

Summary

A Phase 2 randomized, placebo-controlled trial evaluated the efficacy and safety of 5 mg and 10 mg vortioxetine (Lu AA21004) versus placebo, with venlafaxine as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Venlafaxine (Venlafaxine)
• Vortioxetine (vortioxetine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2013-12-17